Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues:
Product sales	$ 3,868,384	$ 656,071
Other revenue	75,673	40,719
Total revenues	3,944,057	696,790
Cost of revenues	2,601,323	420,016
Gross profit	1,342,734	276,774
Operating Expenses:
Selling, general and administrative	11,630,644	6,653,465
Research and development	2,788,887	2,236,985
Total expenses	14,419,531	8,890,450
Loss from operations	(13,076,797)	(8,613,676)
Other Income (Expense):
Interest income	83,272	291,494
Debt forgiveness income	416,683	0
Other	(3,367)	(3,306)
Other income (expense)	496,588	288,188
Net loss	$ (12,580,209)	$ (8,325,488)
Net loss per basic and diluted common share	$ (0.37)	$ (0.29)
Weighted average common shares used to compute net loss per basic and diluted common share	33,846,338	28,652,625
Comprehensive loss
Net loss	$ (12,580,209)	$ (8,325,488)
Net unrealized gain on short-term investments	14,849	0
Comprehensive loss	$ (12,565,360)	$ (8,325,488)